Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1781 37
1782 18
1783 22
1784 27
1785 43
1786 60
1787 43
1788 33
1789 32
1790 44
1791 19
1792 33
1793 17
1794 18
1795 13
1796 15
1797 59
1798 15
1799 291
1800 377
1801 360
1802 283
1803 269
1804 289
1805 314
1806 282
1807 295
1808 289
1809 265
1810 267
1811 322
1812 238
1813 265
1814 285
1815 222
1816 315
1817 288
1818 303
1819 225
1820 213
1821 270
1822 247
1823 291
1824 269
1825 262
1826 385
1827 326
1828 467
1829 645
1830 569
1831 627
1832 313
1833 293
1834 287
1835 305
1836 271
1837 350
1838 484
1839 546
1840 695
1841 1154
1842 1487
1843 1118
1844 1248
1845 1279
1846 1404
1847 1368
1848 1204
1849 1208
1850 1125
1851 1228
1852 1309
1853 1559
1854 1306
1855 1587
1856 1587
1857 1489
1858 1543
1859 1562
1860 1632
1861 1278
1862 1112
1863 995
1864 1139
1865 1153
1866 1477
1867 1724
1868 1813
1869 1909
1870 1809
1871 2238
1872 2242
1873 2313
1874 2510
1875 2404
1876 2095
1877 2180
1878 2454
1879 2400
1880 2647
1881 3150
1882 2744
1883 3131
1884 3051
1885 3339
1886 3291
1887 3966
1888 4003
1889 4196
1890 4025
1891 3578
1892 4095
1893 4370
1894 3802
1895 4130
1896 4413
1897 4688
1898 4632
1899 4169
1900 3787
1901 3887
1902 3968
1903 3910
1904 4060
1905 4067
1906 3872
1907 4323
1908 4514
1909 4766
1910 4885
1911 5099
1912 5016
1913 5251
1914 5243
1915 4702
1916 4569
1917 4323
1918 4595
1919 4717
1920 5037
1921 4703
1922 4192
1923 4519
1924 4945
1925 5058
1926 5397
1927 5945
1928 5537
1929 5798
1930 5694
1931 5572
1932 5630
1933 5695
1934 5577
1935 5736
1936 5448
1937 5378
1938 5829
1939 5615
1940 5024
1941 4865
1942 4800
1943 4543
1944 4764
1945 20491
1946 53908
1947 65002
1948 70711
1949 62804
1950 85755
1951 103748
1952 108064
1953 108915
1954 105914
1955 108544
1956 107007
1957 111522
1958 109458
1959 109963
1960 112145
1961 120105
1962 125636
1963 141521
1964 162087
1965 176646
1966 179760
1967 191560
1968 207874
1969 215064
1970 218981
1971 222966
1972 227561
1973 230705
1974 234603
1975 248367
1976 251720
1977 253817
1978 262809
1979 270573
1980 271605
1981 276085
1982 287749
1983 300341
1984 308762
1985 325469
1986 338364
1987 354755
1988 371767
1989 386511
1990 392532
1991 391261
1992 393721
1993 402778
1994 413873
1995 423262
1996 433562
1997 431479
1998 449537
1999 467434
2000 504864
2001 517574
2002 535712
2003 563603
2004 607451
2005 667483
2006 716269
2007 753518
2008 802058
2009 841913
2010 904976
2011 983749
2012 1054178
2013 1111077
2014 1164771
2015 1205164
2016 1225695
2017 1243083
2018 1288738
2019 1348192
2020 1538939
2021 1673497
2022 1665198
2023 1571181
2024 282908

Text availability

Article attribute

Article type

Publication date

Search Results

35,278,896 results

Results by year

Filters applied: . Clear all
Page 1
A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.
Guo X, Peng Y, Song Q, Wei J, Wang X, Ru Y, Xu S, Cheng X, Li X, Wu D, Chen L, Wei B, Lv X, Ji G. Guo X, et al. Gastroenterology. 2023 Aug;165(2):402-413.e13. doi: 10.1053/j.gastro.2023.02.044. Epub 2023 Mar 7. Gastroenterology. 2023. PMID: 36894035
METHODS: The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastrointestinal cancers. ...Moreover, EV- …
METHODS: The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic ga
Metaplasia in the Stomach-Precursor of Gastric Cancer?
Kinoshita H, Hayakawa Y, Koike K. Kinoshita H, et al. Int J Mol Sci. 2017 Sep 27;18(10):2063. doi: 10.3390/ijms18102063. Int J Mol Sci. 2017. PMID: 28953255 Free PMC article. Review.
Despite a significant decrease in the incidence of gastric cancer in Western countries over the past century, gastric cancer is still one of the leading causes of cancer-related deaths worldwide. Most human gastric cancers develop after long-term Helicobacter pylori infect …
Despite a significant decrease in the incidence of gastric cancer in Western countries over the past century, gastric cancer is still one of …
The importance of CA 72-4 and CA 19-9 dosing in gastric cancer.
Roșu MC, Ardelean A, Moldovan SD, Faur FI, Nesiu A, Totoloci BD. Roșu MC, et al. J Med Life. 2023 Feb;16(2):186-188. doi: 10.25122/jml-2022-0173. J Med Life. 2023. PMID: 36937484 Free PMC article. Review.
Serological analysis of tumor markers has emerged as a non-invasive method for monitoring cancer patients, including tumor recurrence and response to treatment. ...Tumor markers can also provide valuable information on treatment effectiveness, with cha …
Serological analysis of tumor markers has emerged as a non-invasive method for monitoring cancer patients, including tumor rec …
Wei-fu-chun tablet halted gastric intestinal metaplasia and dysplasia associated with inflammation by regulating the NF-kappaB pathway.
Xie D, Wu C, Wang D, Nisma Lena BA, Liu N, Ye G, Sun M. Xie D, et al. J Ethnopharmacol. 2024 Jan 10;318(Pt B):117020. doi: 10.1016/j.jep.2023.117020. Epub 2023 Aug 9. J Ethnopharmacol. 2024. PMID: 37567428
ETHNOPHARMACOLOGICAL RELEVANCE: Chi006Eese herbal medicine Weifuchun Tablets (WFC) approved by the State Food and Drug Administration in 1982 has been widely used in treating a variety of chronic stomach disorders including Chronic atrophic gastritis (CAG) an …
ETHNOPHARMACOLOGICAL RELEVANCE: Chi006Eese herbal medicine Weifuchun Tablets (WFC) approved by the State Food and Drug Administration in 198 …
[Gastrointestinal cancer].
Takahashi Y. Takahashi Y. Gan To Kagaku Ryoho. 2004 Aug;31(8):1275-9. Gan To Kagaku Ryoho. 2004. PMID: 15332558 Review. Japanese.
CEA, CA 19-9, is useful for colon cancer, especially for predicting preoperative staging. Half-life and doubling time of tumor markers is useful in some cases for the evaluation of operation and chemotherapy. ...In most patients with high levels of preoperative CEA …
CEA, CA 19-9, is useful for colon cancer, especially for predicting preoperative staging. Half-life and doubling time of tumor mar
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
Tsai CY, Liu KH, Chiu CT, Hsueh SW, Hung CY, Hsu JT, Tsang NM, Hung YS, Chou WC. Tsai CY, et al. Anticancer Res. 2021 May;41(5):2711-2718. doi: 10.21873/anticanres.15052. Anticancer Res. 2021. PMID: 33952502
PATIENTS AND METHODS: A total of 905 patients with newly diagnosed GC and available pretreatment carcinoembryonic antigen (CEA), cancer-related antigen 19-9 (CA19-9), and AFP data from 2010 to 2016 were collected for comparison of tumor stage and survival. ...
PATIENTS AND METHODS: A total of 905 patients with newly diagnosed GC and available pretreatment carcinoembryonic antigen (CEA …
Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR. Kapadia CR. J Clin Gastroenterol. 2003 May-Jun;36(5 Suppl):S29-36; discussion S61-2. doi: 10.1097/00004836-200305001-00006. J Clin Gastroenterol. 2003. PMID: 12702963 Review.
The main causes of chronic atrophic gastritis and gastric atrophy are autoimmune due to pernicious anemia or chronic Helicobacter pylori infection. ...For the most part, these clinical conditions are silent; the only manifestation of both these forms of ch
The main causes of chronic atrophic gastritis and gastric atrophy are autoimmune due to pernicious anemia or chronic He …
Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis.
Yang Y, Liu YL, Shi HZ. Yang Y, et al. Respiration. 2017;94(1):62-69. doi: 10.1159/000468545. Epub 2017 Apr 21. Respiration. 2017. PMID: 28427079 Free article. Review.
BACKGROUND: The role of combinations of tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antigens (CA) 125, 15-3, and 19-9, and CYFRA 21-1 (a fragment of cytokeratin 19) in diagnosing malignant pleural effusion (MPE) has not been clea …
BACKGROUND: The role of combinations of tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antig …
Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis.
Acharya A, Markar SR, Matar M, Ni M, Hanna GB. Acharya A, et al. Ann Surg Oncol. 2017 May;24(5):1165-1173. doi: 10.1245/s10434-016-5717-y. Epub 2016 Dec 22. Ann Surg Oncol. 2017. PMID: 28008574 Free PMC article. Review.
OBJECTIVE: This study aimed to evaluate the clinical utility of three tumor markers in colorectal and esophagogastric cancer. METHODS: A systematic review of the literature was undertaken to elicit the sensitivity, specificity, statistical heterogeneity and ability …
OBJECTIVE: This study aimed to evaluate the clinical utility of three tumor markers in colorectal and esophagogastric cancer. …
Effect of the coronavirus pandemic on tumor markers.
Purut YE, Giray B, Gurbuz E. Purut YE, et al. J Med Virol. 2021 Sep;93(9):5405-5408. doi: 10.1002/jmv.27057. Epub 2021 Jun 12. J Med Virol. 2021. PMID: 33932304 Free PMC article.
Multiple organ damage can occur rapidly in patients infected with coronavirus disease 2019 (COVID-19). Previous studies have shown that many laboratory biomarkers were not within the normal ranges in COVID-19 patients. We aimed to summarize laboratory parameters and the …
Multiple organ damage can occur rapidly in patients infected with coronavirus disease 2019 (COVID-19). Previous studies have shown that many …
35,278,896 results
You have reached the last available page of results. Please see the User Guide for more information.